TRIM25 and colorectal carcinoma: Furthermore, our data implicate that inhibition of caspase-2 by TRIM25 protects tumor cells from chemotherapeutic drug-induced apoptosis and may constitute a novel mechanism of drug resistance in human colorectal carcinoma cells.